Market Neuron Logo
⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

CRISIL - Investment Analysis: Buy Signal or Bull Trap?

Last Updated Time : 20 Dec 25, 07:05 am

Back to Investment List

Investment Rating: 3.3

Stock Code CRISIL Market Cap 32,018 Cr. Current Price 4,378 ₹ High / Low 6,955 ₹
Stock P/E 48.0 Book Value 271 ₹ Dividend Yield 0.59 % ROCE 39.0 %
ROE 36.5 % Face Value 1.00 ₹ DMA 50 4,612 ₹ DMA 200 4,903 ₹
Chg in FII Hold -0.27 % Chg in DII Hold 0.11 % PAT Qtr 137 Cr. PAT Prev Qtr 194 Cr.
RSI 37.9 MACD -71.6 Volume 1,42,341 Avg Vol 1Wk 61,596
Low price 3,894 ₹ High price 6,955 ₹ PEG Ratio 4.40 Debt to equity 0.12
52w Index 15.8 % Qtr Profit Var -31.7 % EPS 91.3 ₹ Industry PE 29.3

📊 CRISIL shows strong fundamentals with excellent ROCE (39.0%) and ROE (36.5%), supported by low debt-to-equity (0.12). However, valuations are stretched with a high P/E (48.0 vs industry 29.3) and PEG ratio (4.40), suggesting limited upside unless earnings growth accelerates. The sharp quarterly profit decline (-31.7%) raises concerns about earnings consistency. The ideal entry price zone would be between ₹4,000 – ₹4,300, closer to its recent low and below DMA levels, offering margin of safety. If already holding, investors should adopt a long-term horizon (3–5 years), while considering partial profit booking near ₹4,800–₹5,000 and re-entry closer to support zones.

✅ Positive

⚠️ Limitation

📉 Company Negative News

📈 Company Positive News

🏭 Industry

🔎 Conclusion

CRISIL is a moderate long-term candidate with strong fundamentals but stretched valuations and weak earnings momentum. Ideal entry is closer to ₹4,000–₹4,300 for safety. Current holders should adopt a hold with partial profit booking strategy near highs, while maintaining core positions for 3–5 years to benefit from sector growth and financial market expansion.

Would you like me to extend this with a peer benchmarking overlay comparing CRISIL against ICRA, CARE Ratings, and Moody’s India to highlight relative valuation, profitability, and growth strength?

Back to Investment List

NIFTY 50 - Today Top Investment Picks Stock Picks

NEXT 50 - Today Top Investment Picks Stock Picks

MIDCAP - Today Top Investment Picks Stock Picks

SMALLCAP - Today Top Investment Picks Stock Picks